Allergen-specific immunotherapy: Current concepts and future directions

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 66, Issue 6, 2011, Pages 709-712

  Bieber, T ^a   Simon, H U ^b  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; IMMUNOMODULATING AGENT;

ADAPTIVE IMMUNITY; ALLERGY; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); DRUG EFFICACY; DRUG SAFETY; HUMAN; IMMUNOREACTIVITY; IMMUNOTHERAPY; NONHUMAN; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; REVIEW;

ALLERGENS; ANIMALS; DESENSITIZATION, IMMUNOLOGIC; HUMANS; HYPERSENSITIVITY;

EID: 79955409460     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2011.02595.x     Document Type: Review

References (30)

1. Noon L,. Prophylactic inoculation against hayfever. Lancet 1911; 1: 1572.
2. Gutermuth J, Ring J,. 100 years of hyposensitization: history of Allergen-specific immunotherapy (ASIT). Allergy 2011;In press.
3. Crameri R, Fluckiger S, Daigle I, Kundig T, Rhyner C,. Design, engineering and in vitro evaluation of MHC class-II targeting allergy vaccines. Allergy 2007; 62: 197-206. (Pubitemid 46090303)
4. Larche M, Akdis CA, Valenta R,. Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol 2006; 6: 761-771. (Pubitemid 44453462)
5. Lebman DA, Coffman RL,. Interleukin 4 causes isotype switching to IgE in T cell-stimulated clonal B cell cultures. J Exp Med 1988; 168: 853-862.
6. Maggi E, Del Prete G, Macchia D, Parronchi P, Tiri A, Chretien I, et al., Profiles of lymphokine activities and helper function for IgE in human T cell clones. Eur J Immunol 1988; 18: 1045-1050.
7. Rocklin RE, Sheffer AL, Greineder DK, Melmon KL,. Generation of antigen-specific suppressor cells during allergy desensitization. N Engl J Med 1980; 302: 1213-1219. (Pubitemid 10112392)
8. Linden A, Adachi M,. Neutrophilic airway inflammation and IL-17. Allergy 2002; 57: 769-775. (Pubitemid 34969998)
9. Akdis CA, Akdis M, Blesken T, Wymann D, Alkan SS, Muller U, et al., Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J Clin Invest 1996; 98: 1676-1683. (Pubitemid 26327879)
10. Jutel M, Akdis C,. Immunological mechanisms of allergen specific immunotherapy. Allergy 2011;In press.
11. Sabbah A, Hassoun S, Le Sellin J, Andre C, Sicard H,. A double-blind, placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract. Allergy 1994; 49: 309-313. (Pubitemid 24163858)
12. Allam JP, Stojanovski G, Friedrichs N, Peng W, Bieber T, Wenzel J, et al., Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy? Allergy 2008; 63: 720-727. (Pubitemid 351591847)
13. Novak N, Bieber T, Allam JP,. Immunological mechanisms of sublingual allergen-specific immunotherapy. Allergy 2011;In press.
14. Frankland AW, Augustin R,. Prophylaxis of summer hayfever and asthma: controlled trial comparing crude grass pollen extracts with isolated main protein component. Lancet 1954; 1: 1055.
15. Cox L, Calderon MA,. Subcutaneous specific immunotherapy for seasonal allergic rhinitis: a review of treatment practices in the US and Europe. Curr Med Res Opin 2010; 26: 2723-2733.
16. Abramson MJ, Puy RM, Weiner JM,. Allergen immunotherapy for asthma. Cochrane Database Syst Rev 2003; 4: CD001186.
17. Bonifazi F, Jutel M, Bilo BM, Birnbaum J, Muller U,. Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice. Allergy 2005; 60: 1459-1470. (Pubitemid 41654315)
18. Radulovic S, Wilson D, Calderon M, Durham S,. Systematic reviews of sublingual immunotherapy (SLIT). Allergy 2011;In press.
19. Zuberbier T, Bachert C, Bousquet PJ, Passalacqua G, Walter Canonica G, Merk H, et al., GA(2) LEN/EAACI pocket guide for allergen-specific immunotherapy for allergic rhinitis and asthma. Allergy 2010; 65: 1525-1530.
20. Werfel T, Breuer K, Rueff F, Przybilla B, Worm M, Grewe M, et al., Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. Allergy 2006; 61: 202-205. (Pubitemid 43381831)
21. Bussmann C, Bockenhoff A, Henke H, Werfel T, Novak N,. Does allergen-specific immunotherapy represent a therapeutic option for patients with atopic dermatitis? J Allergy Clin Immunol 2006; 118: 1292-1298. (Pubitemid 44854122)
22. Prescott SL, Macaubas C, Smallacombe T, Holt BJ, Sly PD, Holt PG,. Development of allergen-specific T-cell memory in atopic and normal children. Lancet 1999; 353: 196-200. (Pubitemid 29088031)
23. Des Roches A, Paradis L, Menardo JL, Bouges S, Daures JP, Bousquet J,. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 1997; 99: 450-453. (Pubitemid 27173080)
24. Bousquet J, Schünemann HJ, Bousquet PJ, Bachert C, Canonica G, Casale TB, et al., How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis. An ARIA-GA2LEN statement. Allergy 2011;In press.
25. Canonica GW, Baena-Cagnani CE, Bousquet J, Bousquet PJ, Lockey RF, Malling HJ, et al., Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. Allergy 2007; 62: 317-324.
26. Bousquet PJ, Brozek J, Bachert C, Bieber T, Bonini S, Burney P, et al., The CONSORT statement checklist in allergen-specific immunotherapy: a GA2LEN paper. Allergy 2009; 64: 1737-1745.
27. Kaul S, May S, Luttkopf D, Vieths S, Regulatory environment for allergen-specific immunotherapy. Allergy 2011;In press.
28. Larche M, Immunotherapy with peptides. Allergy 2011;In press.
29. Kopp MV, Role of immunmodulators in allergen-specific immunotherapy. Allergy 2011;In press.
30. Kündig T, Senti G, von Moos S, Epicutaneous allergen administration: is this the future of allergen specific immunotherapy? Allergy 2011;In press.